ID: ALA327145

Max Phase: Preclinical

Molecular Formula: C22H29N3O2

Molecular Weight: 367.49

Molecule Type: Small molecule

Associated Items:

Representations

Canonical SMILES:  OCCN1CCN(CCCCN2c3ccccc3Oc3ccccc32)CC1

Standard InChI:  InChI=1S/C22H29N3O2/c26-18-17-24-15-13-23(14-16-24)11-5-6-12-25-19-7-1-3-9-21(19)27-22-10-4-2-8-20(22)25/h1-4,7-10,26H,5-6,11-18H2

Standard InChI Key:  OTSPMDFTLZQWKE-UHFFFAOYSA-N

Associated Targets(Human)

KB 17409 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

GC3/Cl 69 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Properties

Molecular Weight: 367.49Molecular Weight (Monoisotopic): 367.2260AlogP: 3.32#Rotatable Bonds: 7
Polar Surface Area: 39.18Molecular Species: NEUTRALHBA: 5HBD: 1
#RO5 Violations: 0HBA (Lipinski): 5HBD (Lipinski): 1#RO5 Violations (Lipinski): 0
CX Acidic pKa: CX Basic pKa: 8.19CX LogP: 2.92CX LogD: 2.07
Aromatic Rings: 2Heavy Atoms: 27QED Weighted: 0.76Np Likeness Score: -0.71

References

1. Thimmaiah KN, Horton JK, Seshadri R, Israel M, Houghton JA, Harwood FC, Houghton PJ..  (1992)  Synthesis and chemical characterization of N-substituted phenoxazines directed toward reversing vinca alkaloid resistance in multidrug-resistant cancer cells.,  35  (18): [PMID:1527786] [10.1021/jm00096a009]

Source